Rare Diseases Act of 2002
E421900
The Rare Diseases Act of 2002 is a U.S. federal law that expanded national efforts to identify, study, and develop treatments for rare diseases by strengthening research infrastructure and coordination.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Rare Diseases Act of 2002 canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T4210297 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Rare Diseases Act of 2002 Context triple: [Office of Rare Diseases Research, legalBasis, Rare Diseases Act of 2002]
-
A.
Orphan Drug Act of 1983
The Orphan Drug Act of 1983 is a U.S. law that incentivizes the development of treatments for rare diseases by offering benefits such as market exclusivity, tax credits, and research grants to drug manufacturers.
-
B.
Genetic Information Nondiscrimination Act of 2008
The Genetic Information Nondiscrimination Act of 2008 is a U.S. federal law that prohibits discrimination in health insurance and employment based on individuals’ genetic information.
-
C.
Food and Drug Administration Amendments Act of 2007
The Food and Drug Administration Amendments Act of 2007 is a U.S. law that expanded the FDA’s authority over drug and device safety, clinical trials, and post-market surveillance, while enhancing transparency and user fee programs.
-
D.
Food and Drug Administration Modernization Act of 1997
The Food and Drug Administration Modernization Act of 1997 is a U.S. law that overhauled FDA regulatory procedures to speed the approval of drugs and medical devices while enhancing patient access to experimental therapies and modernizing agency operations.
-
E.
Healthcare Research and Quality Act of 1999
The Healthcare Research and Quality Act of 1999 is a U.S. federal law that reauthorized and strengthened the nation’s health services research infrastructure, establishing a focused mission to improve the quality, safety, efficiency, and effectiveness of healthcare.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Rare Diseases Act of 2002 Target entity description: The Rare Diseases Act of 2002 is a U.S. federal law that expanded national efforts to identify, study, and develop treatments for rare diseases by strengthening research infrastructure and coordination.
-
A.
Orphan Drug Act of 1983
The Orphan Drug Act of 1983 is a U.S. law that incentivizes the development of treatments for rare diseases by offering benefits such as market exclusivity, tax credits, and research grants to drug manufacturers.
-
B.
Genetic Information Nondiscrimination Act of 2008
The Genetic Information Nondiscrimination Act of 2008 is a U.S. federal law that prohibits discrimination in health insurance and employment based on individuals’ genetic information.
-
C.
Food and Drug Administration Amendments Act of 2007
The Food and Drug Administration Amendments Act of 2007 is a U.S. law that expanded the FDA’s authority over drug and device safety, clinical trials, and post-market surveillance, while enhancing transparency and user fee programs.
-
D.
Food and Drug Administration Modernization Act of 1997
The Food and Drug Administration Modernization Act of 1997 is a U.S. law that overhauled FDA regulatory procedures to speed the approval of drugs and medical devices while enhancing patient access to experimental therapies and modernizing agency operations.
-
E.
Healthcare Research and Quality Act of 1999
The Healthcare Research and Quality Act of 1999 is a U.S. federal law that reauthorized and strengthened the nation’s health services research infrastructure, establishing a focused mission to improve the quality, safety, efficiency, and effectiveness of healthcare.
- F. None of above. chosen
Statements (30)
| Predicate | Object |
|---|---|
| instanceOf |
Act of Congress
ⓘ
United States federal law ⓘ |
| affects |
National Institutes of Health
ⓘ
Office of Rare Diseases Research ⓘ |
| aimsToBenefit |
patients with rare diseases
ⓘ
rare disease researchers ⓘ |
| chamberInvolved |
United States House of Representatives
ⓘ
United States Senate ⓘ |
| country | United States of America ⓘ |
| establishesOrAuthorizes | federal programs for rare disease research coordination ⓘ |
| field |
health policy
ⓘ
medical research policy ⓘ |
| focusesOn | rare diseases ⓘ |
| jurisdiction |
United States federal government
ⓘ
linked to:
United States government
|
| legislativeBody | United States Congress ⓘ |
| policyArea |
biomedical research
ⓘ
public health ⓘ |
| presidentAtTimeOfSigning | George W. Bush ⓘ |
| purpose |
to expand national efforts to develop treatments for rare diseases
ⓘ
to expand national efforts to identify rare diseases ⓘ to expand national efforts to study rare diseases ⓘ to improve coordination of rare disease research ⓘ to strengthen rare disease research infrastructure ⓘ |
| regulates | federal support for rare disease research ⓘ |
| relatedTo |
Orphan Drug Act
ⓘ
linked to:
Orphan Drug Act of 1983
|
| signedBy | George W. Bush ⓘ |
| topic | orphan diseases ⓘ |
| typeOfImpact |
enhanced coordination of rare disease activities at the national level
ⓘ
expansion of research infrastructure ⓘ |
| yearEnacted | 2002 ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Rare Diseases Act of 2002 Description of subject: The Rare Diseases Act of 2002 is a U.S. federal law that expanded national efforts to identify, study, and develop treatments for rare diseases by strengthening research infrastructure and coordination.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.